Published in Biochem Biophys Res Commun on March 16, 2011
Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease. PLoS One (2012) 0.95
Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus. J Biol Chem (2012) 0.92
Targeting UDP-galactopyranose mutases from eukaryotic human pathogens. Curr Pharm Des (2013) 0.85
UDP-galactopyranose mutase in nematodes. Biochemistry (2013) 0.84
Noncanonical reactions of flavoenzymes. Int J Mol Sci (2012) 0.83
Towards the crystal structure elucidation of eukaryotic UDP-galactopyranose mutase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.82
Agrobacterium tumefaciens exoR controls acid response genes and impacts exopolysaccharide synthesis, horizontal gene transfer, and virulence gene expression. J Bacteriol (2014) 0.77
UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis. Arch Biochem Biophys (2013) 0.77
Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J (1964) 35.63
Leishmaniasis. Lancet (1999) 7.20
Galactofuranose-containing glycoconjugates in trypanosomatids. Glycobiology (1995) 2.32
Galactofuranose biosynthesis in Escherichia coli K-12: identification and cloning of UDP-galactopyranose mutase. J Bacteriol (1996) 1.95
Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J Bacteriol (2001) 1.90
The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci U S A (2003) 1.89
UDP-galactopyranose mutase has a novel structure and mechanism. Nat Struct Biol (2001) 1.70
Cutaneous leishmaniasis. Clin Dermatol (2007) 1.61
Enhanced bacterial protein expression during auto-induction obtained by alteration of lac repressor dosage and medium composition. Biotechnol Prog (2007) 1.51
Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumigatus. Eukaryot Cell (2008) 1.47
Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol (2001) 1.45
Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem (2009) 1.43
High efficiency single step production of expression plasmids from cDNA clones using the Flexi Vector cloning system. Protein Expr Purif (2005) 1.38
Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens. Eukaryot Cell (2005) 1.36
Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins. Proc Natl Acad Sci U S A (2009) 1.30
HaloTag7: a genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification. Protein Expr Purif (2009) 1.27
Targeted gene deletion of Leishmania major UDP-galactopyranose mutase leads to attenuated virulence. J Biol Chem (2007) 1.22
Identification of inhibitors for UDP-galactopyranose mutase. J Am Chem Soc (2004) 1.19
Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus. Arch Biochem Biophys (2010) 1.13
Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues. Biochemistry (2007) 1.12
Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases. Biol Chem (2005) 1.11
Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes. J Am Chem Soc (2001) 1.11
Deficiency in beta1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. J Biol Chem (1996) 1.07
Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. J Mol Biol (2009) 1.07
Molecular epidemiology for vector research on leishmaniasis. Int J Environ Res Public Health (2010) 1.06
Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors. PLoS Negl Trop Dis (2010) 1.02
Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies. Biochim Biophys Acta (2007) 0.93
A Protein Structure Initiative approach to expression, purification, and in situ delivery of human cytochrome b5 to membrane vesicles. Protein Expr Purif (2007) 0.90
Role of beta-D-galactofuranose in Leishmania major macrophage invasion. Infect Immun (2002) 0.85
Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus. Arch Biochem Biophys (2010) 1.13
Aspergillus fumigatus SidA is a highly specific ornithine hydroxylase with bound flavin cofactor. Biochemistry (2010) 1.04
A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications. Autophagy (2015) 1.00
Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus. J Biol Chem (2012) 0.97
Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease. PLoS One (2012) 0.95
Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' disease. Enzyme Res (2011) 0.94
Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation. Biochemistry (2012) 0.92
Structural insight into the mechanism of oxygen activation and substrate selectivity of flavin-dependent N-hydroxylating monooxygenases. Biochemistry (2012) 0.88
Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutase. J Am Chem Soc (2012) 0.86
Targeting UDP-galactopyranose mutases from eukaryotic human pathogens. Curr Pharm Des (2013) 0.85
Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design. Protein Sci (2013) 0.84
Substrate binding modulates the activity of Mycobacterium smegmatis G, a flavin-dependent monooxygenase involved in the biosynthesis of hydroxamate-containing siderophores. Biochemistry (2011) 0.84
Dual role of NADP(H) in the reaction of a flavin dependent N-hydroxylating monooxygenase. Biochim Biophys Acta (2012) 0.83
Recombinant expression, purification, and characterization of ThmD, the oxidoreductase component of tetrahydrofuran monooxygenase. Arch Biochem Biophys (2010) 0.82
Mechanistic and structural studies of H373Q flavocytochrome b2: effects of mutating the active site base. Biochemistry (2007) 0.82
Fluorescence Polarization Binding Assay for Aspergillus fumigatus Virulence Factor UDP-Galactopyranose Mutase. Enzyme Res (2011) 0.81
Monitoring the reductive and oxidative half-reactions of a flavin-dependent monooxygenase using stopped-flow spectrophotometry. J Vis Exp (2012) 0.78
UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis. Arch Biochem Biophys (2013) 0.77
Role of Ser-257 in the sliding mechanism of NADP(H) in the reaction catalyzed by the Aspergillus fumigatus flavin-dependent ornithine N5-monooxygenase SidA. J Biol Chem (2013) 0.77
Tryptophan-47 in the active site of Methylophaga sp. strain SK1 flavin-monooxygenase is important for hydride transfer. Arch Biochem Biophys (2013) 0.77
C4a-hydroperoxyflavin formation in N-hydroxylating flavin monooxygenases is mediated by the 2'-OH of the nicotinamide ribose of NADP⁺. Biochemistry (2013) 0.76
Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics. Biochemistry (2014) 0.76
A fluorescence polarization binding assay to identify inhibitors of flavin-dependent monooxygenases. Anal Biochem (2012) 0.76
Mechanism of N-hydroxylation catalyzed by flavin-dependent monooxygenases. J Org Chem (2015) 0.75
Developmental expression of Xenopus myosin 1d and identification of a myo1d tail homology that overlaps TH1. Dev Growth Differ (2009) 0.75